© 2002 by European Society of Cardiology
Copyright © 2002, European Society of Cardiology
Ovarian hormones induce TGF-β3 and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation
aDepartément de Physiologie, Université de Montréal, Montréal, Québec, Canada
bInstitut de Cardiologie de Montréal, 5000 rue Belanger est, Montréal, Québec, Canada H1T 1C8
cDepartément de Biochimie, Université de Montréal, Montréal, Québec, Canada
* Corresponding author. Tel.: +1-514-376-3330x3710; fax: +1-514-376-1355 calderon{at}icm.umontreal.ca
Prior to menopause, women have a lower risk of cardiovascular disease compared to age-matched men. Despite the well-documented beneficial physiological effects of ovarian hormones on vascular reactivity and growth, very little is known with regard to the direct action on cardiac cells. Objective: The following study examined the pattern of ovarian hormone receptor subtype expression in cardiac fibroblasts, the modulator role of 17β-estradiol and progesterone on growth and their respective influence on putative molecular events of extracellular matrix remodeling. Methods and results: Neonatal rat cardiac fibroblasts were isolated from 1- to 3-day-old Sprague–Dawley rats. Immunofluorescence and Western blot analysis revealed the presence of estrogen receptor-
(ER-), and -β (ER-β) subtypes, with the ER- subtype localized on the plasma membrane. Likewise, both progesterone receptor-A (PR-A), and -B (PR-B) subtypes were expressed in cardiac fibroblasts, and the PR-B appeared to be the predominant subtype associated with the plasma membrane. Despite the presence of both ER subtypes, the treatment of cardiac fibroblasts with 1 µM 17β-estradiol exerted a modest decrease in DNA synthesis. By contrast, progesterone treatment caused a dose-dependent decrease in [3H]thymidine uptake, without a concomitant induction of apoptosis. The progesterone-mediated decrease in DNA synthesis was associated with the upregulation of the cyclin-dependent kinase inhibitor p27Kip1, whereas p21cip and proliferating cell nuclear antigen protein levels were unchanged. Lastly, despite the modest effect on DNA synthesis, 17β-estradiol increased the steady-state mRNA levels of transforming growth factor-β3 and fibronectin. Likewise, progesterone increased the expression of both transforming growth factor-β3, and fibronectin mRNA. Conclusion: Collectively, these data are the first to highlight the presence of estrogen and progesterone receptor subtypes on the plasma membrane of neonatal rat cardiac fibroblasts, and further underscore the ability of ovarian hormones to directly suppress DNA synthesis, and influence putative molecular events associated with extracellular matrix remodeling.
KEYWORDS Fibrosis; Gender; Hormones; Receptors
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Tian, Z. Wu, Y. Zhao, Y. Meng, Y. Si, X. Fu, Y. Mu, and W. Han Differential induction of LRP16 by liganded and unliganded estrogen receptor {alpha} in SKOV3 ovarian carcinoma cells J. Endocrinol., July 1, 2009; 202(1): 167 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Aubin, C. Lajoie, R. Clement, H. Gosselin, A. Calderone, and L. P. Perrault Female Rats Fed a High-Fat Diet Were Associated with Vascular Dysfunction and Cardiac Fibrosis in the Absence of Overt Obesity and Hyperlipidemia: Therapeutic Potential of Resveratrol J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 961 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Groban, L. M. Yamaleyeva, B. M. Westwood, T. T. Houle, M. Lin, D. W. Kitzman, and M. C. Chappell Progressive Diastolic Dysfunction in the Female mRen(2).Lewis Rat: Influence of Salt and Ovarian Hormones J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2008; 63(1): 3 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Burstein, A. Maguy, R. Clement, H. Gosselin, F. Poulin, N. Ethier, J.-C. Tardif, T. E. Hebert, A. Calderone, and S. Nattel Effects of Resveratrol (trans-3,5,4'-Trihydroxystilbene) Treatment on Cardiac Remodeling following Myocardial Infarction J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 916 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Straub The Complex Role of Estrogens in Inflammation Endocr. Rev., August 1, 2007; 28(5): 521 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Han, J. S. Heo, and Y. J. Lee Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1067 - C1075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J M O'Donnell, K. G Macleod, D. J Burns, J. F Smyth, and S. P Langdon Estrogen receptor-{alpha} mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen Endocr. Relat. Cancer, December 1, 2005; 12(4): 851 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H-H Chao, J-J Chen, C-H Chen, H Lin, C-F Cheng, W-S Lian, Y-L Chen, S-H Juan, J-C Liu, J-Y Liou, et al. Inhibition of angiotensin II induced endothelin-1 gene expression by 17-{beta}-oestradiol in rat cardiac fibroblasts Heart, May 1, 2005; 91(5): 664 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Boverhof, K. C. Fertuck, L. D. Burgoon, J. E. Eckel, C. Gennings, and T. R. Zacharewski Temporal- and dose-dependent hepatic gene expression changes in immature ovariectomized mice following exposure to ethynyl estradiol Carcinogenesis, July 1, 2004; 25(7): 1277 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Mercier, S. Mader, and A. Calderone Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism Cardiovasc Res, October 1, 2003; 59(4): 883 - 892. [Abstract] [Full Text] [PDF]
|
|